Perfil del autor: Olbrich, Peter
Datos institucionales
Nombre | Olbrich, Peter |
Departamento | Farmacología, Pediatría y Radiología |
Área de conocimiento | Pediatría |
Categoría profesional | Profesor Permanente Laboral-Mod.PCD (V) |
Correo electrónico | Solicitar |
Estadísticas
-
Nº publicaciones
14
-
Nº visitas
1011
-
Nº descargas
1755
Publicaciones |
---|
Artículo
Inborn errors of immunity causing pediatric susceptibility to fungal diseases
(MDPI, 2023)
Inborn errors of immunity are a heterogeneous group of genetically determined disorders that compromise the immune system, ... |
Artículo
SARS-CoV-2 Seroprevalence Study in Pediatric Patients and Health Care Workers Using Multiplex Antibody Immunoassays
(MDPI, 2022)
SARS-CoV-2 infection has become a global health problem specially exacerbated with the continuous appearance of new variants. ... |
Artículo
Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations—10 Children and Review of the Literature
(SPRINGER, 2022)
Introduction Since the frst description of gain of function (GOF) mutations in signal transducer and activator of transcrip ... |
Artículo
Ex vivo efect of JAK inhibition on JAK‑STAT1 pathway hyperactivation in patients with dominant‑negative STAT3 mutations
(SPRINGER, 2022)
Purpose STAT1 gain-of-function (GOF) and dominant-negative (DN) STAT3 syndromes share clinical manifestations includ ing ... |
Artículo
Examining the immune signatures of SARS-CoV-2 infection in pregnancy and the impact on neurodevelopment: protocol of the SIGNATURE longitudinal study
(FRONTIERS MEDIA SA, 2022)
The COVID-19 pandemic represents a valuable opportunity to carry out cohort studies that allow us to advance our knowledge ... |
Artículo
Colchicine treatment in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: A multicenter study in Spain
(AVES, 2021)
Objective: To evaluate the efficacy of colchicine therapy in pediatric patients with PFAPA syndrome who present with an ... |
Artículo
Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management
(Frontiers Media, 2021)
Primary immune regulatory disorders (PIRD) are associated with autoimmunity, autoinflammation and/or dysregulation of ... |
Artículo
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
(Mosby-Elsevier, 2021)
Background Inborn errors of immunity (IEI) are rare diseases, which makes diagnosis a challenge. A better description of ... |
Artículo
STAT1 Gain-of-Function Mutations Cause High Total STAT1 Levels With Normal Dephosphorylation
(Frontiers Media S.A., 2019)
Signal transducer and activator of transcription (STAT1)1 gain of function (GOF) pathogenic variants have been associated ... |
Artículo
Secondary C1q Deficiency in Activated PI3K delta Syndrome Type 2
(Frontiers Media S.A., 2019)
Monogenic forms of vasculitis are rare but increasingly recognized. Furthermore, genetic immunodeficiency is increasingly ... |
Artículo
Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs, Diagnosis, and Management
(Frontiers Media S.A., 2019)
Background: Immunodeficiencies (ID), in particular primary immunodeficiencies (PID), are often associated with haematological ... |
Artículo
Disease evolution and response to rapamycin in Activated Phosphoinositide 3-Kinase delta syndrome: the european society for immunodeficiencies-Activated Phosphoinositide 3-Kinase d syndrome registry
(Frontiers Media S.A., 2018)
Activated phosphoinositide 3-kinase (PI3K) δ Syndrome (APDS), caused by autosomal dominant mutations in PIK3CD (APDS1) or ... |
Artículo
Newborn Screening for Primary T- and B-Cell Immune Deficiencies—A Prospective Study in Andalucía
(MDPI, 2017)
Background: Quantification of T-cell-receptor-excision circles (TRECs) and kappa-deleting-recombination-excision circles ... |
Tesis Doctoral
Impacto de la lecitina de unión a la manosa (MBL) y beta-defensina 2 en la susceptibilidad frente a infecciones en neonatos prematuros extremos
(2015)
Introducción: Los recién nacidos prematuros extremos (< 32 semanas de edad gestacional, EG) son una población de riesgo ... |